ES2369720T5 - Arilsulfonamidas - Google Patents
Arilsulfonamidas Download PDFInfo
- Publication number
- ES2369720T5 ES2369720T5 ES07004318.7T ES07004318T ES2369720T5 ES 2369720 T5 ES2369720 T5 ES 2369720T5 ES 07004318 T ES07004318 T ES 07004318T ES 2369720 T5 ES2369720 T5 ES 2369720T5
- Authority
- ES
- Spain
- Prior art keywords
- ccr9
- compounds
- antagonists
- inflammation
- assays
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Photoreceptors In Electrophotography (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Holo Graphy (AREA)
Description
Claims (1)
-
imagen1 imagen2 imagen3
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42767002P | 2002-11-18 | 2002-11-18 | |
US427670P | 2002-11-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2369720T3 ES2369720T3 (es) | 2011-12-05 |
ES2369720T5 true ES2369720T5 (es) | 2014-11-06 |
Family
ID=32326578
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03796416T Expired - Lifetime ES2286502T3 (es) | 2002-11-18 | 2003-11-17 | Sulfonamidas de arilo. |
ES07004318.7T Expired - Lifetime ES2369720T5 (es) | 2002-11-18 | 2003-11-17 | Arilsulfonamidas |
ES03816012T Expired - Lifetime ES2299766T3 (es) | 2002-11-18 | 2003-11-18 | Bis-arilo sulfonamidas. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03796416T Expired - Lifetime ES2286502T3 (es) | 2002-11-18 | 2003-11-17 | Sulfonamidas de arilo. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03816012T Expired - Lifetime ES2299766T3 (es) | 2002-11-18 | 2003-11-18 | Bis-arilo sulfonamidas. |
Country Status (17)
Country | Link |
---|---|
US (7) | US6939885B2 (es) |
EP (4) | EP2256116A3 (es) |
JP (3) | JP4611746B2 (es) |
KR (3) | KR100866456B1 (es) |
CN (3) | CN100360526C (es) |
AT (3) | ATE363470T1 (es) |
AU (4) | AU2003298661B2 (es) |
CA (2) | CA2500492C (es) |
DE (2) | DE60314175T2 (es) |
DK (3) | DK1562940T3 (es) |
ES (3) | ES2286502T3 (es) |
HK (3) | HK1113792A1 (es) |
IL (2) | IL167714A (es) |
MX (1) | MXPA05005296A (es) |
PT (2) | PT1562940E (es) |
WO (2) | WO2004046092A2 (es) |
ZA (3) | ZA200503663B (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329159B1 (en) | 1999-03-11 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function |
WO2003099773A1 (en) | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
KR100866456B1 (ko) * | 2002-11-18 | 2008-10-31 | 케모센트릭스 | 아릴 술폰아마이드 |
US7741519B2 (en) * | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
US7420055B2 (en) * | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
US7288538B2 (en) | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
WO2005113513A2 (en) * | 2004-05-12 | 2005-12-01 | Chemocentryx | Aryl sulfonamides |
US7622583B2 (en) | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
MX2007008474A (es) * | 2005-01-14 | 2008-02-19 | Chemocentryx Inc | Sulfonamidas de heteroarilo y ccr2. |
WO2007014054A2 (en) * | 2005-07-22 | 2007-02-01 | Glaxo Group Limted | Benzenesulfonamide inhibitor of ccr2 chemokine receptor |
FI20055498A0 (fi) * | 2005-09-16 | 2005-09-16 | Biotie Therapies Corp | Sulfonamidijohdannaisia |
GB0526445D0 (en) * | 2005-12-23 | 2006-02-08 | Novartis Ag | Organic compounds |
TWI417096B (zh) * | 2006-01-25 | 2013-12-01 | Synta Pharmaceuticals Corp | 用於發炎及免疫相關用途之苯基及吡啶基化合物 |
KR100746342B1 (ko) | 2006-04-10 | 2007-08-03 | 한국과학기술원 | 구리 촉매 존재하에서 n―설포닐아미드 화합물의 제조방법 |
ES2358618T3 (es) * | 2006-07-14 | 2011-05-12 | Chemocentryx, Inc. | Triazol piridil bencenosulfonamidas como moduladores del ccr2 o ccr9 para el tratamiento de la arteriosclerosis. |
US20100234364A1 (en) * | 2006-07-14 | 2010-09-16 | Arindrajit Basak | Ccr2 inhibitors and methods of use thereof |
US8519135B2 (en) * | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
US7718683B2 (en) * | 2006-07-14 | 2010-05-18 | Chemocentryx, Inc. | Triazolyl phenyl benzenesulfonamides |
ATE498615T1 (de) * | 2006-07-14 | 2011-03-15 | Chemocentryx Inc | Triazolylphenylbenzensulfonamide |
WO2008095908A1 (en) * | 2007-02-06 | 2008-08-14 | Novartis Ag | 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity |
US8283351B2 (en) * | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
US7776877B2 (en) | 2007-06-22 | 2010-08-17 | Chemocentryx, Inc. | N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides |
CN101820881B (zh) * | 2007-07-12 | 2013-05-01 | 坎莫森特里克斯公司 | 作为ccr2调节剂用于治疗炎症的稠合杂芳基吡啶基和苯基苯磺酰胺 |
CA2699328A1 (en) * | 2007-09-24 | 2009-04-02 | Actelion Pharmaceuticals Ltd | Pyrrolidines and piperidines as orexin receptor antagonists |
AU2008306533A1 (en) * | 2007-10-05 | 2009-04-09 | Encysive Pharmaceuticals Inc. | Thiophene-2-carboxamide derivatives as modulators of CCR9 receptor |
WO2009131951A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
EP2278879B1 (en) | 2008-04-21 | 2016-06-15 | PATH Drug Solutions | Compounds, compositions and methods comprising oxadiazole derivatives |
EP2341776A4 (en) * | 2008-09-19 | 2012-05-30 | Inst Oneworld Health | COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING IMIDAZOL AND TRIAZOL DERIVATIVES |
US20120129858A1 (en) * | 2009-04-20 | 2012-05-24 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
CN101838240A (zh) * | 2010-06-11 | 2010-09-22 | 扬州康伊尔医药科技有限公司 | 抗病毒化合物中间体吡唑-3-羧酸酯的制备方法 |
UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
DK2704742T3 (en) | 2011-05-02 | 2017-10-23 | Millennium Pharm Inc | FORMULATION FOR ANTI-4-7 ANTIBODY |
JP6166721B2 (ja) * | 2011-07-22 | 2017-07-19 | ケモセントリックス, インコーポレイテッド | 4−tert−ブチル−N−[4−クロロ−2−(1−オキシ−ピリジン−4−カルボニル)−フェニル]−ベンゼンスルホンアミドのナトリウム塩の多形 |
ES2625286T3 (es) * | 2011-07-22 | 2017-07-19 | Chemocentryx, Inc. | Una forma cristalina de la sal sódica de 4-terc-butil-n-[4-cloro-2-(1-oxi-piridin-4-carbonil)-fenil]-bencenosulfonamida |
AU2012287233B2 (en) * | 2011-07-22 | 2017-07-20 | Chemocentryx, Inc. | Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide |
US9458147B2 (en) | 2012-02-22 | 2016-10-04 | Sanford-Burnham Medical Research Institute | Sulfonamide compounds and uses as TNAP inhibitors |
ES2645617T3 (es) * | 2012-02-29 | 2017-12-07 | Chemocentryx, Inc. | Pirazol-1-il benceno sulfonamidas como antagonistas del CCR9 |
US9181190B2 (en) | 2012-07-04 | 2015-11-10 | Concert Pharmaceuticals, Inc. | Deuterated vercirnon |
TW201438717A (zh) | 2012-12-04 | 2014-10-16 | Takeda Pharmaceutical | 預防或治療蕭格倫徵候群之方法 |
EP3141235A1 (en) * | 2012-12-06 | 2017-03-15 | IP Gesellschaft für Management mbH | N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorobenzylthio)pyrimidin-4-yl)-3-methylazetidine-l -sulfonamide |
JP2017501145A (ja) | 2013-12-23 | 2017-01-12 | ノージン ビーブイ | Ccr9調節因子として有用な化合物 |
JP2017503772A (ja) | 2013-12-23 | 2017-02-02 | ノージン ビーブイ | Ccr9阻害剤としてのベンゼンスルホンアミド |
EP2950011B1 (en) * | 2014-05-29 | 2019-08-28 | Panasonic Intellectual Property Corporation of America | Method for controlling terminal apparatus that remotely controls air conditioner and terminal apparatus |
IL251136B (en) * | 2014-10-06 | 2022-07-01 | Chemocentryx Inc | Combined treatment of c-c receptor inhibitors type 9 (ccr9) and integrin-blocking anti-alha4beta7 antibodies |
JP2017537105A (ja) | 2014-11-26 | 2017-12-14 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 瘻孔を伴うクローン病の治療用ベドリズマブ |
MA41636A (fr) | 2015-03-06 | 2018-01-09 | Millennium Pharm Inc | Méthode de traitement de la cholangite sclérosante primitive |
KR20180101565A (ko) | 2016-01-20 | 2018-09-12 | 케모센트릭스, 인크. | 2-옥신돌 화합물 |
MX2018011025A (es) | 2016-03-14 | 2019-01-10 | Millennium Pharm Inc | Metodos para tratar o prevenir la enfermedad del injerto contra huésped. |
IL261750B1 (en) | 2016-03-14 | 2024-03-01 | Millennium Pharm Inc | A method for preventing graft-versus-host disease |
PL3464272T3 (pl) | 2016-06-07 | 2022-03-28 | Jacobio Pharmaceuticals Co., Ltd. | Nowe pochodne heterocykliczne użyteczne jako inhibitory SHP2 |
BR112019010375A2 (pt) | 2016-11-23 | 2019-08-27 | Chemocentryx Inc | método de tratamento de glomeruloesclerose segmental focal |
MA49013A (fr) | 2017-03-23 | 2021-05-05 | Jacobio Pharmaceuticals Co Ltd | Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2 |
WO2018200818A2 (en) | 2017-04-28 | 2018-11-01 | Millennium Pharmaceuticals, Inc. | Method of treating pediatric disorders |
WO2019075086A1 (en) | 2017-10-11 | 2019-04-18 | Chemocentryx, Inc. | TREATMENT OF FOCAL SEGMENTAL GLOBEROSCLEROSIS WITH CCR2 ANTAGONISTS |
BR112021025888A2 (pt) | 2019-07-10 | 2022-04-26 | Chemocentryx Inc | Indanos como inibidores de pd-l1 |
US10792360B1 (en) | 2019-11-21 | 2020-10-06 | Chemocentryx, Inc. | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies |
TW202203916A (zh) * | 2020-03-31 | 2022-02-01 | 美商卡默森屈有限公司 | 使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法 |
Family Cites Families (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US65303A (en) * | 1867-05-28 | Improvement in wood-splitting machines | ||
US37928A (en) * | 1863-03-17 | Improvement in lamps | ||
US139390A (en) * | 1873-05-27 | Improvement in ore-washers | ||
US103202A (en) * | 1870-05-17 | Improvement in automatic railway-switches | ||
US13314A (en) * | 1855-07-24 | Parlor-stove | ||
US72530A (en) * | 1867-12-24 | Augustus w | ||
US60460A (en) * | 1866-12-18 | barrabe | ||
US9116A (en) * | 1852-07-13 | Railroad-car brake | ||
US37905A (en) * | 1863-03-17 | Improvement in sheep-racks | ||
US12680A (en) * | 1855-04-10 | Railroad-cab | ||
US2997368A (en) * | 1956-12-20 | 1961-08-22 | Barent Mark | Production of manganese hydroxide |
GB884847A (en) | 1958-04-14 | 1961-12-20 | Ciba Ltd | Mercapto compounds |
US3121077A (en) * | 1961-10-20 | 1964-02-11 | Hoffmann La Roche | Substituted-1, 4-benzodiazepine-2-one compounds |
US3442946A (en) * | 1960-04-26 | 1969-05-06 | Hoffmann La Roche | 2-aminomercapto- and 2-aminoalkylcaptobenzophenone oximes |
US3336295A (en) * | 1960-12-02 | 1967-08-15 | Hoffmann La Roche | Hydroxy or alkoxy substituted 5-phenyl-3h-1, 4-benzodiazepin-2(1h)-ones |
US3534062A (en) * | 1967-05-16 | 1970-10-13 | Upjohn Co | Dibenzothiadiazocines |
CH491126A (de) | 1967-10-20 | 1970-05-31 | Sandoz Ag | Verfahren zur Herstellung neuer 2-(o-Aminobenzoyl)thiophene |
US3551427A (en) | 1969-05-09 | 1970-12-29 | Sandoz Ag | 4-thienyl-2-(1h)-quinazolones |
CH561703A5 (en) | 1970-12-11 | 1975-05-15 | Hoffmann La Roche | 7-Iodobenzodiazepin-2-ones - sedatives etc prepd by cyclising iodobenzophenones with glycine (esters) |
GB1332697A (en) | 1970-12-21 | 1973-10-03 | Hoffmann La Roche | Benzodiazepine derivatives |
BE791902A (fr) | 1971-11-26 | 1973-05-24 | Wander Ag Dr A | Nouveaux derives de la thieno (3,2-c) (1)benzazepine, leur preparation et leur application comme medicaments |
CH585222A5 (en) | 1973-02-14 | 1977-02-28 | Wander Ag Dr A | Prepn. of antipsychotic heterocyclic piperazine derivs. - by reaction of heterocyclic ketones with metal piperazine complexes |
US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
FR2403330A1 (fr) * | 1977-06-16 | 1979-04-13 | Fabre Sa Pierre | Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments |
FR2449677B1 (fr) | 1979-02-26 | 1986-03-28 | Fabre Sa Pierre | Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
JPS61113060A (ja) | 1984-11-08 | 1986-05-30 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
DD251126A1 (de) * | 1984-12-21 | 1987-11-04 | Univ Berlin Humboldt | Verfahren zur herstellung neuer 2-arylsulfonamido-benzo- und -acetophenone und deren oxime, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
US5010195A (en) * | 1988-05-25 | 1991-04-23 | The Dow Chemical Company | Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides |
US4997940A (en) * | 1986-07-11 | 1991-03-05 | The Dow Chemical Company | Pyrazolo[1,5-a]pyrimidine-2-sulfonyl chloride and -2-sulfide compounds |
US5021591A (en) * | 1986-07-11 | 1991-06-04 | The Dow Chemical Company | Pyrazolo[1,5-a]pyrimidine-2-sulfide compounds |
US4992091A (en) * | 1986-07-11 | 1991-02-12 | The Dow Chemical Company | Substituted pyrazolo[1,5-a]pyrimidine-2-sulfonamides and compositions and methods of controlling undesired vegetation |
US4780488A (en) * | 1986-08-29 | 1988-10-25 | Ciba-Geigy Corporation | Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing polyoxyalkylene backbone units, and use thereof |
JPH0753725B2 (ja) * | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
DE3825041A1 (de) | 1988-07-20 | 1990-02-15 | Schering Ag | Pyrido(3,2-e)(1,2,4)triazolo(1,5-a)pyrimidin- 2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwachstumsregulierender und fungizider wirkung |
GB8820129D0 (en) * | 1988-08-24 | 1988-09-28 | Schering Agrochemicals Ltd | Fungicides |
GB8830182D0 (en) * | 1988-12-23 | 1989-02-22 | Shell Int Research | Heterocyclic herbicides |
US5217521A (en) * | 1989-12-22 | 1993-06-08 | Ciba-Geigy Corporation | Triazolylsulfonamides |
US5338755A (en) * | 1990-07-31 | 1994-08-16 | Elf Sanofi | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
US5481005A (en) * | 1990-07-31 | 1996-01-02 | Sanofi | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
FR2679903B1 (fr) | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
JPH04364168A (ja) | 1990-08-08 | 1992-12-16 | Taisho Pharmaceut Co Ltd | スルホンアミドピリジン化合物 |
DE4025818A1 (de) * | 1990-08-16 | 1992-02-20 | Bayer Ag | Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate |
US5185348A (en) * | 1990-08-16 | 1993-02-09 | Bayer Aktiengesellschaft | Phenylsulphonamide substituted pyridinealkene- and -aminooxyalkanecarboxylic acid derivatives |
JPH06145145A (ja) | 1991-12-27 | 1994-05-24 | Ishihara Sangyo Kaisha Ltd | アミノトリフルオロメチルピリジン誘導体又はその塩、それらの製造方法及びそれらを含有するホスホリパーゼa▲2▼阻害剤、抗炎症剤並びに抗膵炎剤 |
EP0556673B1 (de) | 1992-02-15 | 1997-09-17 | Hoechst Aktiengesellschaft | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
GB2271770B (en) * | 1992-10-20 | 1996-08-07 | Kodak Ltd | Photographic couplers, photographic materials containing them and dyes derived therefrom |
NZ250916A (en) | 1993-02-27 | 1995-08-28 | Nihon Nohyaku Co Ltd | N-heteroaryl-n'-phenylureas, their use as acat inhibitors |
US5514555A (en) | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
WO1995033462A1 (en) | 1994-06-02 | 1995-12-14 | Smithkline Beecham Corporation | Anti-inflammatory compounds |
US5571775A (en) * | 1994-07-11 | 1996-11-05 | Dowelanco | N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides |
FR2724654B1 (fr) | 1994-09-16 | 1997-12-12 | Roussel Uclaf | Nouveaux derives de l'acide gallique, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
US5780488A (en) * | 1996-04-03 | 1998-07-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
DE19629144A1 (de) * | 1996-07-19 | 1998-01-22 | Bayer Ag | Substituierte Triazoloazinsulfonamide |
EP0925358B1 (en) | 1996-09-10 | 2007-04-25 | Theodor-Kocher Institute | Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
ZA9710197B (en) * | 1996-11-13 | 1999-05-12 | Dow Agrosciences Llc | N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
SE9604786D0 (sv) | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
US6696475B2 (en) | 1997-04-22 | 2004-02-24 | Neurosearch A/S | Substituted phenyl derivatives, their preparation and use |
AU7473398A (en) | 1997-05-07 | 1998-11-27 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
KR20010021643A (ko) * | 1997-07-11 | 2001-03-15 | 피터 기딩스 | 5-ht6수용체길항제인술폰아미드유도체및그의제조방법 |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
AU1529799A (en) | 1997-12-23 | 1999-07-12 | Warner-Lambert Company | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
DE69939864D1 (de) * | 1998-01-29 | 2008-12-18 | Amgen Inc | Ppar-gamma modulatoren |
GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
WO1999055324A1 (en) * | 1998-04-27 | 1999-11-04 | Smithkline Beecham Corporation | Ccr-3 receptor antagonists |
JP2002512997A (ja) | 1998-04-29 | 2002-05-08 | バーテックス ファーマシューティカルズ インコーポレイテッド | Impdh酵素のインヒビター |
US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
WO2000005214A2 (en) | 1998-07-24 | 2000-02-03 | Pfizer Inc. | Isoquinolines as urokinase inhibitors |
US6030408A (en) * | 1998-10-22 | 2000-02-29 | East West Medical Llp | Acupressure treatment device |
US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
ID30460A (id) | 1999-04-15 | 2001-12-06 | Bristol Myers Squibb Co | Inhibitor-inhibitor protein siklik tirosin kinase |
US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
DK1192137T3 (da) | 1999-06-30 | 2013-11-11 | Amgen Inc | Forbindelser til modulering af PPAR-gamma aktivitet |
WO2001009097A1 (en) | 1999-07-30 | 2001-02-08 | Vertex Pharmaceuticals Incorporated | Cyclic amine derivatives for the treatment of neurological diseases |
WO2001017971A1 (fr) | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Procede de preparation de derives 2,3-dihydroazepine |
KR100760434B1 (ko) | 1999-09-17 | 2007-10-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 벤즈아미드 및 관련된 Xa 인자의 억제제 |
NZ517828A (en) | 1999-09-17 | 2003-10-31 | Millennium Pharm Inc | Inhibitors having activity against mammalian factor Xa |
JP2001089412A (ja) | 1999-09-22 | 2001-04-03 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体またはその医薬的に許容される塩 |
GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
WO2001056989A2 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
EP1255743A1 (en) | 2000-02-01 | 2002-11-13 | Millenium Pharmaceuticals, Inc. | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
WO2001057020A1 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa |
HUP0300544A3 (en) | 2000-02-03 | 2005-03-29 | Eisai Co Ltd | Pharmaceutical compositions containing integrin expression inhibitors |
EP1214070A4 (en) | 2000-02-18 | 2008-07-16 | Arch Dev Corp | COMPOUNDS WITH POLY-HYDROXYLATED BENZENE |
AU2001243158A1 (en) * | 2000-02-18 | 2001-08-27 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
JP3842976B2 (ja) | 2000-03-17 | 2006-11-08 | 富士通株式会社 | 分布帰還型半導体レーザとその製造方法 |
EP1267618A1 (en) * | 2000-03-28 | 2003-01-02 | The Regents Of The University Of California | Methods for increasing a cytotoxic t lymphocyte response in vivo |
WO2001082916A2 (en) | 2000-05-03 | 2001-11-08 | Tularik Inc. | Combination therapeutic compositions and methods of use |
JP2002031867A (ja) * | 2000-05-08 | 2002-01-31 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料の処理方法 |
EP1296977A1 (en) | 2000-06-23 | 2003-04-02 | Bristol-Myers Squibb Pharma Company | Heteroaryl-phenyl substituted factor xa inhibitors |
AU7163701A (en) | 2000-06-28 | 2002-01-08 | Tularik Inc | Quinolinyl and benzothiazolyl ppar-gamma modulators |
AU2001280167A1 (en) | 2000-08-31 | 2002-03-13 | Wakunaga Pharmaceutical Co.,Ltd | Novel propenohydroxamic acid derivatives |
AU2002213467A8 (en) * | 2000-10-11 | 2009-07-30 | Chemocentryx Inc | Modulation of ccr4 function |
US20020147198A1 (en) | 2001-01-12 | 2002-10-10 | Guoqing Chen | Substituted arylamine derivatives and methods of use |
AR032230A1 (es) | 2001-01-16 | 2003-10-29 | Sumitomo Chem Takeda Agro Co | Derivado sulfonamida conteniendo una composicion agricola y horticola |
US6656971B2 (en) | 2001-01-25 | 2003-12-02 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
WO2002101350A2 (en) | 2001-06-07 | 2002-12-19 | Chemocentryx | Cell migration assay |
WO2003099773A1 (en) * | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
KR100866456B1 (ko) * | 2002-11-18 | 2008-10-31 | 케모센트릭스 | 아릴 술폰아마이드 |
US20060111351A1 (en) * | 2002-11-18 | 2006-05-25 | Solomon Ungashe | Aryl sulfonamides |
US7420055B2 (en) * | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
EP1643960A2 (en) | 2003-07-02 | 2006-04-12 | Merck & Co., Inc. | Arylsulfonamide derivatives |
US20080214672A1 (en) * | 2006-12-18 | 2008-09-04 | John Jessen Wright | Treatment of Asthma with Aryl Sulfonamides |
US9715915B2 (en) | 2014-10-30 | 2017-07-25 | Samsung Electronics Co., Ltd. | Magneto-resistive devices including a free layer having different magnetic properties during operations |
-
2003
- 2003-11-17 KR KR1020057005798A patent/KR100866456B1/ko active IP Right Grant
- 2003-11-17 PT PT03796416T patent/PT1562940E/pt unknown
- 2003-11-17 US US10/716,170 patent/US6939885B2/en not_active Expired - Lifetime
- 2003-11-17 DK DK03796416T patent/DK1562940T3/da active
- 2003-11-17 AT AT03796416T patent/ATE363470T1/de active
- 2003-11-17 AT AT07004318T patent/ATE517102T1/de active
- 2003-11-17 CN CNB2003801033356A patent/CN100360526C/zh not_active Expired - Lifetime
- 2003-11-17 WO PCT/US2003/036766 patent/WO2004046092A2/en active IP Right Grant
- 2003-11-17 CA CA2500492A patent/CA2500492C/en not_active Expired - Lifetime
- 2003-11-17 EP EP10009944A patent/EP2256116A3/en not_active Withdrawn
- 2003-11-17 JP JP2004553842A patent/JP4611746B2/ja not_active Expired - Lifetime
- 2003-11-17 AU AU2003298661A patent/AU2003298661B2/en not_active Expired
- 2003-11-17 PT PT07004318T patent/PT1798223E/pt unknown
- 2003-11-17 KR KR1020067025189A patent/KR100874292B1/ko active IP Right Grant
- 2003-11-17 DK DK07004318.7T patent/DK1798223T4/da active
- 2003-11-17 DE DE60314175T patent/DE60314175T2/de not_active Expired - Lifetime
- 2003-11-17 ES ES03796416T patent/ES2286502T3/es not_active Expired - Lifetime
- 2003-11-17 ES ES07004318.7T patent/ES2369720T5/es not_active Expired - Lifetime
- 2003-11-17 EP EP03796416A patent/EP1562940B1/en not_active Expired - Lifetime
- 2003-11-17 EP EP07004318.7A patent/EP1798223B2/en not_active Expired - Lifetime
- 2003-11-17 CN CN2007101270116A patent/CN101077867B/zh not_active Expired - Lifetime
- 2003-11-18 JP JP2004569975A patent/JP2006510724A/ja active Pending
- 2003-11-18 CN CN200380108668A patent/CN100582091C/zh not_active Expired - Lifetime
- 2003-11-18 DE DE60318740T patent/DE60318740T2/de not_active Expired - Lifetime
- 2003-11-18 EP EP03816012A patent/EP1567486B1/en not_active Expired - Lifetime
- 2003-11-18 AU AU2003303942A patent/AU2003303942B9/en not_active Expired
- 2003-11-18 MX MXPA05005296A patent/MXPA05005296A/es active IP Right Grant
- 2003-11-18 KR KR1020057008974A patent/KR100780905B1/ko not_active IP Right Cessation
- 2003-11-18 ES ES03816012T patent/ES2299766T3/es not_active Expired - Lifetime
- 2003-11-18 CA CA002505590A patent/CA2505590A1/en not_active Abandoned
- 2003-11-18 US US10/716,183 patent/US20040167113A1/en not_active Abandoned
- 2003-11-18 DK DK03816012T patent/DK1567486T3/da active
- 2003-11-18 AT AT03816012T patent/ATE384041T1/de active
- 2003-11-18 WO PCT/US2003/037035 patent/WO2004085384A2/en active IP Right Grant
-
2005
- 2005-01-27 US US11/046,565 patent/US7582661B2/en active Active
- 2005-03-29 IL IL167714A patent/IL167714A/en unknown
- 2005-05-06 ZA ZA2005/03663A patent/ZA200503663B/en unknown
- 2005-05-17 ZA ZA200503986A patent/ZA200503986B/xx unknown
- 2005-05-18 ZA ZA200504015A patent/ZA200504015B/en unknown
- 2005-05-18 IL IL168661A patent/IL168661A/en active IP Right Grant
-
2006
- 2006-06-19 HK HK08103764.0A patent/HK1113792A1/xx not_active IP Right Cessation
- 2006-06-19 HK HK06106974A patent/HK1086839A1/xx not_active IP Right Cessation
- 2006-08-18 HK HK06109180.5A patent/HK1088888A1/xx not_active IP Right Cessation
- 2006-11-17 JP JP2006311085A patent/JP4611962B2/ja not_active Expired - Lifetime
-
2007
- 2007-08-09 AU AU2007205711A patent/AU2007205711B2/en not_active Expired
-
2008
- 2008-07-02 US US12/166,844 patent/US20080293717A1/en not_active Abandoned
- 2008-10-15 US US12/251,829 patent/US20090118307A1/en not_active Abandoned
-
2009
- 2009-07-07 US US12/498,633 patent/US20090270616A1/en not_active Abandoned
-
2010
- 2010-05-11 AU AU2010201893A patent/AU2010201893A1/en not_active Ceased
- 2010-10-01 US US12/896,114 patent/US8211896B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2369720T5 (es) | Arilsulfonamidas | |
MX2007008474A (es) | Sulfonamidas de heteroarilo y ccr2. | |
DK1531822T3 (da) | 1-aryl-4-substituerede piperazin derivater til anvendelse som CCR1 antagonister til behandlingen af inflammation og immunforstyrrelser | |
ATE498615T1 (de) | Triazolylphenylbenzensulfonamide | |
WO2008008431A3 (en) | Heteroaryl sulfonamides and ccr2/ccr9 | |
ATE496905T1 (de) | Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose | |
UY28034A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparacion asi como su empleo como medicamentos | |
WO2008008374A3 (en) | Ccr2 inhibitors and methods of use thereof | |
ECSP066311A (es) | Derivados de la piperazina y su uso como agentes terapéuticos | |
ATE398125T1 (de) | Chinazolin-derivate als tgf-beta-inhibitoren | |
CY1106801T1 (el) | Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα | |
BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
CY1110863T1 (el) | Παραγωγα του 2-(8,9-διοξο-2,6-διαζαδικυκλο (5.2.0)-εννε-1(7)-εν-2-υλ)αλκυλ-φωσφονικου οξεος και η χρηση τους ως ανταγωνιστων του ν-μεθυλ- d-ασπαρτικου (nmda) υποδοχεα | |
CY1112727T1 (el) | Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3 | |
EA200602154A1 (ru) | Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5 | |
EA200100157A2 (ru) | Новые производные арил- или гетероарилхинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
TH65566A (th) | สารประกอบชนิดใหม่ต่าง ๆ | |
CY1115497T1 (el) | Αναστολεις κινασης πυρρολοτριαζινης |